You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 12, December 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  CASE REPORTS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Postoperative Rhodotorula Endophthalmitis

Jeff K. Gregory, MD; Julia A. Haller, MD
Baltimore, Md

Arch Ophthalmol. 1992;110(12):1686-1687.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Rhodotorula is a ubiquitous, airborne, asporogenous yeast that has been cultured from food, air, soil, water, gastrointestinal tracts, and skin. This normally nonpathogenic organism has produced occasional infections in patients with serious underlying illnesses.1 It is a rare saprophyte of the conjunctiva, cultured, in one study, from only one of 304 healthy eyes, and isolated from three eyes of 313 patients with chronic external infections.2 We report a case of endophthalmitis due to Rhodotorula.

Report of a Case.

—A 71-year-old-white woman with atrophic age-related macular degeneration was referred to us 4 months after cataract surgery with chronic inflammation in the left eye. She developed epiphora, photophobia, and erythema 2 months after uncomplicated surgery in the left eye. She was treated with topical steroids, and her condition initially improved. However, the symptoms recurred after a few weeks. Several relapses had been treated with increasing topical steroid dosages. Four months . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.